← DRIPTEIN
Private investment overview
An asset-light bet on pourable protein.
DRIPTEIN is a pre-development, high-protein whey syrup positioned for durable repeat consumption and an asset-light, co-manufactured cost base.
$1M Pre-Seed · returns overview
PE Pitch Deck · May 2026 · A Hyperius Holdings venture · Currently in development
A high-margin format in a category that keeps buying
01 — DURABLE DEMAND
Repeat by design
A daily-ritual consumable — poured over food people already eat — drives habitual reorder.
02 — ASSET-LIGHT
No owned plant
Co-manufactured production and 3PL fulfillment keep capital intensity low and scalable.
03 — MARGIN HEADROOM
Branded premium
A differentiated "first to pour" position supports pricing power over commodity protein.
Pre-development — thesis pillars, not current performance02
A whey protein syrup you pour, not shake
>20g
Protein / serving
~100
Calories / serving
Chocolate RushCinnamon BoostVanilla Surge
Full nutrition panel, format & price TBD post-development
A large category with structural, repeat demand
$66B
Global protein supplements by 2034 (9.1% CAGR)
~$480B
U.S. wellness market, +5–10% / yr
Consumable, not durable
Every pour is consumed — built-in replenishment, not a one-time purchase.
Habit, not hype
Anchored to existing daily routines (breakfast, coffee), reducing fad risk.
Mainstream, not niche
Protein demand spans demographics — broad, non-cyclical pull.
Category figures — Grand View Research; McKinsey. Not DRIPTEIN revenue.04
Recurring revenue, multiple channels
CORE
DTC subscription
Predictable recurring revenue & first-party data
REACH
Marketplace
Amazon & protein marketplaces for low-CAC volume
SCALE
Retail wholesale
Grocery, club & specialty distribution at scale
MARGIN
Foodservice
Café & gym pour-stations — high-frequency usage
Channel mix & pricing TBD post-development05
From shelf price to contribution
Net price / bottle TBD
– Ingredients & whey
– Packaging & bottle
– Co-manufacturing & fill
– Fulfillment & fees
= Contribution / bottle
Illustrative cost structure for shape only — every line finalized post-development & co-man quotes06
Designed to recover CAC fast, then compound
TARGET
60%+
Gross margin at scale assumption
TARGET
<6 mo
CAC payback via subscription assumption
TARGET
3–4×
LTV : CAC over customer life assumption
Pre-revenue targets, not results. Validated with formulation, pricing & cohort data.07
Margin scales as revenue grows
RevenueOperating cost % of revenueEBITDA-positive
EBITDA crossover timing TBD
Y1
Y5
Illustrative operating-leverage shape — not a forecast08
A co-manufactured, capital-light supply chain
SUPPLY
Whey & ingredients
Contracted suppliers, COA-tested partners TBD
→
MAKE
Co-manufacturer
Blend, fill & bottle under contract — no owned plant
→
MOVE
3PL & retail DCs
Warehousing & fulfillment scale on demand
→
SELL
DTC · retail
Brand owns demand, data & margin
Low fixed capital → cash converts to growth, not plant09
Deploying
$1M
Pre-Seed to first revenue & proof points
35%
Product development, formulation & co-man setup
30%
Brand, launch & demand generation
20%
First production runs & inventory
15%
Team & working capital assumption
Unlocks: launch-ready product, first DTC cohorts & a real unit-economics model10
Scenario returns on a $1M entry
| Scenario | Path | Exit horizon | MoIC | IRR |
|---|---|---|---|---|
| Bear | Slow adoption, raise dilution before traction | 5–6 yr | TBD | TBD |
| Base | DTC scale + retail pilots, strategic acquisition | 4–5 yr | TBD | TBD |
| Bull | Category leadership, competitive M&A premium | 3–4 yr | TBD | TBD |
Scenario framework only — MoIC/IRR require a completed model & entry terms11
Four levers compound the return
01
Margin expansion
Scale whey buys & co-man runs lower COGS per bottle.
02
Channel mix
Shift toward subscription & foodservice lifts LTV.
03
Line extension
New flavors & formats raise AOV with shared supply.
04
Distribution
Retail doors multiply volume on a fixed cost base.
Each lever is independent — multiple shots at multiple expansion12
Known risks, deliberate mitigants
| Risk | Mitigant |
|---|---|
| Pre-development product | Stage-gated spend; capital released against formulation & co-man milestones. |
| Formulation & taste | Multiple flavor trials and panel testing before any production commitment. |
| CAC inflation | Subscription + organic/creator engine to balance paid acquisition. |
| Co-man dependence | Qualify multiple manufacturers; avoid single-source lock-in. |
| Competitive entry | First-mover brand, IP on format/positioning, speed to shelf. |
Risk register evolves through development13
13 — THE ASK
$1M Pre-Seed to convert a concept into a returns story
INSTRUMENT
SAFE / equity
Structure & valuation TBD
DEPLOYMENT
~18 months
To launch + first cohort proof assumption
NEXT ROUND
Priced Seed
On validated unit economics & traction
admin@hyperius.site · Currently in developmentAll figures illustrative